Stay updated on Nivolumab and Ipilimumab Combination Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.

Latest updates to the Nivolumab and Ipilimumab Combination Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding lapse notice and the prior Revision: v3.4.1.SummaryDifference0.3%

- Check21 days agoChange DetectedAn administrative government funding notice was added and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedMinor UI and metadata updates were applied: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 were added, while Melanoma and related topics such as MedlinePlus Genetics were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedMelanoma was added to related topics, and MedlinePlus Genetics was added as a related topic.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 was added to the page. The term 'Melanoma' and related topics (MedlinePlus Genetics) were removed, along with the prior 'Revision: v3.3.3' note.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded related topic links for Melanoma and MedlinePlus Genetics on the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Ipilimumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.